Quasiparticles

Apr 08, 2020

Soliton Granted New Key Patent for FDA Cleared RAP Technology

Oct 15, 2019

Soliton's FDA Cleared RAP Device is Granted Two Additional Key Patents

Aug 26, 2019

Soliton Engages argodesign in Preparation of Commercial Launch of its RAP Device

Aug 16, 2019

Dr. Michael Kaminer Presented Soliton RAP for Cellulite at Key Dermatology Conference

Jul 23, 2019

Soliton's FDA Cleared Device is Granted Key Patent

Jul 08, 2019

Soliton to Announce Cellulite Trial Data for 26-Week Period on July 15, 2019

Jun 28, 2019

Soliton's Inclusion in the Russell 2000 and 3000 will be Effective After the Close of the Market Today

Jun 25, 2019

Soliton Engages CRO to begin Pivotal Cellulite Trial

May 14, 2019

Soliton Receives Approval for New Patent for its Acoustic Shockwave Technology

Apr 23, 2019

Soliton Announces Global Partner Completes Second Generation RAP Device to More Effectively Target Cellulite Reduction

Apr 22, 2019

Keio University Research: Air Pollution and Environmental Monitoring

Sep 22, 2017

NUST MISIS Scientists Develop Gold Nanoparticles for Cancer Treatment